1. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. (2010) LPA receptors: subtypes and biological actions.
Annu Rev Pharmacol Toxicol, 50: 157-86.
[PMID:20055701]
2. Garozzo R, Zuccarini M, Giuliani P, Di Liberto V, Mudò G, Caciagli F, Ciccarelli R, Ciruela F, Di Iorio P, Condorelli DF. (2022) Guanine inhibits the growth of human glioma and melanoma cell lines by interacting with GPR23.
Front Pharmacol, 13: 970891.
[PMID:36199684]
3. Hata E, Sasaki N, Takeda A, Tohya K, Umemoto E, Akahoshi N, Ishii S, Bando K, Abe T, Kano K et al.. (2016) Lysophosphatidic acid receptors LPA4 and LPA6 differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes.
Int Immunol, 28 (6): 283-92.
[PMID:26714589]
4. Igarashi H, Akahoshi N, Ohto-Nakanishi T, Yasuda D, Ishii S. (2015) The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells.
Sci Rep, 5: 11410.
[PMID:26090649]
5. Kano K, Arima N, Ohgami M, Aoki J. (2008) LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
Curr Med Chem, 15 (21): 2122-31.
[PMID:18781939]
6. Kano K, Matsumoto H, Inoue A, Yukiura H, Kanai M, Chun J, Ishii S, Shimizu T, Aoki J. (2019) Molecular mechanism of lysophosphatidic acid-induced hypertensive response.
Sci Rep, 9 (1): 2662.
[PMID:30804442]
7. Lee Z, Cheng CT, Zhang H, Subler MA, Wu J, Mukherjee A, Windle JJ, Chen CK, Fang X. (2008) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
Mol Biol Cell, 19 (12): 5435-45.
[PMID:18843048]
8. Noguchi K, Ishii S, Shimizu T. (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
J Biol Chem, 278 (28): 25600-6.
[PMID:12724320]
9. Ohuchi H, Hamada A, Matsuda H, Takagi A, Tanaka M, Aoki J, Arai H, Noji S. (2008) Expression patterns of the lysophospholipid receptor genes during mouse early development.
Dev Dyn, 237 (11): 3280-94.
[PMID:18924241]
10. Southern C, Cook JM, Neetoo-Isseljee Z, Taylor DL, Kettleborough CA, Merritt A, Bassoni DL, Raab WJ, Quinn E, Wehrman TS et al.. (2013) Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein-Coupled Receptors.
J Biomol Screen, 18 (5): 599-609.
[PMID:23396314]
11. Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, Sato S, Tamaki K, Morishita Y, Kano MR et al.. (2010) LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis.
Blood, 116 (23): 5060-70.
[PMID:20713964]
12. Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS, Santini AM, Hutchinson JH et al.. (2010) A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
Br J Pharmacol, 160 (7): 1699-713.
[PMID:20649573]
13. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, Fujiwara Y. (2009) Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
J Biol Chem, 284 (25): 17304-19.
[PMID:19366702]
14. Wu C, Rakhshandehroo T, Wettersten HI, Campos A, von Schalscha T, Jain S, Yu Z, Tan J, Mose E, Childers BG et al.. (2023) Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation.
Nat Cell Biol, 25 (2): 309-322.
[PMID:36646789]
15. Yanagida K, Igarashi H, Yasuda D, Kobayashi D, Ohto-Nakanishi T, Akahoshi N, Sekiba A, Toyoda T, Ishijima T, Nakai Y et al.. (2018) The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity.
JCI Insight, 3 (24).
[PMID:30568036]
16. Yanagida K, Ishii S, Hamano F, Noguchi K, Shimizu T. (2007) LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.
J Biol Chem, 282 (8): 5814-24.
[PMID:17172642]
17. Yang L, Kraemer M, Fang XF, Angel PM, Drake RR, Morris AJ, Smyth SS. (2019) LPA receptor 4 deficiency attenuates experimental atherosclerosis.
J Lipid Res, 60 (5): 972-980.
[PMID:30796085]
18. Yasuda D, Kobayashi D, Akahoshi N, Ohto-Nakanishi T, Yoshioka K, Takuwa Y, Mizuno S, Takahashi S, Ishii S. (2019) Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
J Clin Invest, 129 (10): 4332-4349.
[PMID:31335323]